Microrna in combination with her2-targeting drugs reduces breast cancer cell viability in vitro
HIGHLIGHTS who: Lisa Svartdal Normann from the DepartmentUniversity Hospital have published the research: MicroRNA in combination with HER2-targeting drugs reduces […]